Antonio da Silva Menezes Junior, Isabela Jube Wastowski, Lilian Carla Carneiro
{"title":"Fibro-Inflammatory Signaling, Fibrosis, and Microvascular Ischemia as Convergent Translational Substrates of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: A Systematic Review.","authors":"Antonio da Silva Menezes Junior, Isabela Jube Wastowski, Lilian Carla Carneiro","doi":"10.1007/s12265-026-10853-w","DOIUrl":"10.1007/s12265-026-10853-w","url":null,"abstract":"<p><p>Hypertrophic cardiomyopathy (HCM) remains an important cause of sudden cardiac death (SCD), but the biological determinants of ventricular arrhythmic vulnerability remain incompletely defined. This systematic translational review examined whether fibro-inflammatory signaling, fibrotic remodeling, and microvascular ischemia represent convergent components of the arrhythmogenic substrate in HCM. MEDLINE/PubMed, Embase, Web of Science Core Collection, and Cochrane Library were searched from inception to January 2026. Of 167 records, 37 full-text reports were assessed and 11 studies included. Fibrosis emerged as the most clinically mature substrate marker, while microvascular ischemia appeared to amplify electrical instability, particularly in remodeled myocardium. Molecular and tissue studies suggested upstream fibro-inflammatory programs involving activated fibroblasts, extracellular matrix dysregulation, SMAD/TGF-beta signaling, CRLF1/LIFR-JAK-STAT signaling, and altered multicellular communication. Overall, the evidence supports an integrated mechanism-to-substrate model, but prospective outcome-validated studies are needed before these biological layers can refine SCD risk stratification beyond established clinical and imaging markers in contemporary HCM practice.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13661659/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149182028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vid Mirosevic, Tanja Blagus, Tomo Svagusa, Ana Livun, Petra Bakovic, Ana Sepac, Ana Kulic, Vita Dolzan, Filip Sedlic
{"title":"Higher Myocardial miR-1-3p, miR-30a-5p, miR-34a-5p, and Lower miR208a-3p Levels are Associated with Lower Age at the Time of Heart Transplantation.","authors":"Vid Mirosevic, Tanja Blagus, Tomo Svagusa, Ana Livun, Petra Bakovic, Ana Sepac, Ana Kulic, Vita Dolzan, Filip Sedlic","doi":"10.1007/s12265-026-10854-9","DOIUrl":"10.1007/s12265-026-10854-9","url":null,"abstract":"<p><p>Expression of microRNAs (miR-1-3p, miR-21-3p, miR-30a-5p, miR-34a-5p, miR-133a-3p, miR-208a-3p, and miR-423-5p) and mitochondrial unfolded protein response (UPRmt) genes (HSPA9, HSPD1, LONP1, OMA1, and YME1L) was investigated by qRT-PCR in six controls and 65 failing human hearts (33 ischemic cardiomyopathy (ICM), 28 dilated cardiomyopathy (DCM), 2 hypertrophic cardiomyopathy, and 1 non-compaction and restrictive cardiomyopathy each). Failing hearts had higher expression of miR-208a-3p, HSPA9, HSPD1, OMA1, YME1L and lower miR-1-3p expression compared to controls. Patients with higher miR-1-3p, miR-30a-5p, miR-34a-5p, (miR-423-5p exhibited a trend) and lower miR-208a-3p expression underwent heart transplantation or LVAD implantation earlier in life. DCM group had higher expression of miR-1-3p, miR-30a-5p, HSPD1, and LONP1 compared to the ICM group. Thus, myocardial expression of miR-1-3p, miR-30a-5p, miR-34a-5p, and miR-208a-3p could be associated with the HF progression; miR-208a-3p, HSPA9, HSPD1, OMA1, YME1L, and miR-1-3p could discriminate HF form control; and miR-1-3p, miR-30a-5p, HSPD1, and LONP1 could discriminate DCM from ICM.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149136792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ruilin He, Shujie Wu, Que Xu, Yifan Lin, Xiaohui Niu, Suwei Weng, Jiafeng Lin
{"title":"α7-nAChR Activation is Associated with Attenuation of Cardiac Fibrosis in Ischemic Cardiomyopathy via SIRT3-Dependent Modulation of EndMT.","authors":"Ruilin He, Shujie Wu, Que Xu, Yifan Lin, Xiaohui Niu, Suwei Weng, Jiafeng Lin","doi":"10.1007/s12265-026-10857-6","DOIUrl":"10.1007/s12265-026-10857-6","url":null,"abstract":"<p><p>To investigate whether α7-nicotinic acetylcholine receptor (α7-nAChR) activation attenuates ischemic cardiomyopathy (ICM) through regulation of endothelial-to-mesenchymal transition (EndMT), and to explore the involvement of Sirtuin-3 (SIRT3) in this process. ICM was induced in rats by coronary ligation for 4 weeks, followed by treatment with PNU-282,987, a selective α7-nAChR agonist, or cardiac-specific SIRT3 knockdown using serotype 9 adeno-associated virus (AAV9). Human umbilical vein endothelial cells (HUVECs) were treated with transforming growth factor-β (TGF-β) and/or PNU-282,987 (10 µM). α7-nAChR activation improved cardiac function, reversed ICM-induced TGF-β upregulation and SIRT3 downregulation, and inhibited EndMT-related changes. These effects were weakened by SIRT3 knockdown. The findings suggest that α7-nAChR activation alleviates ICM and myocardial fibrosis through a SIRT3-dependent mechanism, although direct receptor-level specificity requires further validation.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149136801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"YAP and WWTR1/TAZ Connect Mechanotransduction and Mitochondrial Metabolism in Cardiac Hypertrophy and Ventricular Remodeling.","authors":"Feihu Yu, Zuqiu Liu, Jimiao Qiu, Huashan Chen, Xiaowei Song, Songqun Huang, Changjin Li","doi":"10.1007/s12265-026-10858-5","DOIUrl":"10.1007/s12265-026-10858-5","url":null,"abstract":"<p><p>Cardiac hypertrophy is a mechanometabolic remodeling process shaped by mechanical load, matrix stiffness and mitochondrial adaptation. YAP and TAZ, encoded by YAP1 and WWTR1, are paralogous, non-DNA-binding transcriptional co-activators that link cytoskeletal tension to TEAD-dependent transcription. This review organizes current evidence along a mechanical stress-YAP/TAZ activation-mitochondrial remodeling-ventricular remodeling axis and distinguishes direct human myocardial data, animal cardiac mechanisms, related cardiovascular or in vitro evidence, and cross-disease extrapolation. Experimental studies suggest that TEAD1 supports mitochondrial gene programs, transient YAP activation promotes glycolytic compensation during early pressure overload, whereas sustained Yap1 activation may impair mitochondrial biogenesis. Cell-specific studies further implicate fibroblast, endothelial, immune and epicardial programs, although many data derive from non-hypertrophic contexts. Thus, the adaptive-to-maladaptive YAP/TAZ model remains provisional. Human lineage-resolved data are limited, and no YAP/TAZ-targeted therapy is established for cardiac hypertrophy.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149136795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chunyan Duan, Jing Sun, Shijun Chen, Zhengshi Wang, Lin Sun, Chengyou Jia, Xiankai Li
{"title":"Stacking Ensemble Learning for Diagnosing Acute Myocardial Infarction in Mice Using Plasma Raman Spectroscopy and Mass Spectrometry.","authors":"Chunyan Duan, Jing Sun, Shijun Chen, Zhengshi Wang, Lin Sun, Chengyou Jia, Xiankai Li","doi":"10.1007/s12265-026-10856-7","DOIUrl":"10.1007/s12265-026-10856-7","url":null,"abstract":"<p><p>Cardiac troponin is the reference biomarker for acute myocardial infarction (AMI) but has limited utility in the hyperacute phase. Raman spectroscopy enables rapid, label-free molecular analysis, whereas mass spectrometry offers greater molecular specificity at higher cost. Plasma from 57 coronary-ligated or Sham-operated mice underwent Raman spectroscopy and mass spectrometry. A stacking ensemble model was developed to identify AMI using Raman spectroscopy, mass spectrometry, or fused data. Under nested cross-validation, the Raman spectroscopy model yielded an area under the receiver operating characteristic curve (AUC) of 0.807 (95% CI [0.679, 0.910]). Mass spectrometry and fused models achieved 1.000 (95% CI [1.000, 1.000]), and fusion showed no detectable improvement over mass spectrometry. Cardiac troponin I demonstrated 0.714 (95% CI [0.567, 0.842]), significantly lower than mass spectrometry and fused models (Holm-adjusted p < 0.001) and numerically lower than the Raman spectroscopy model (Holm-adjusted p = 0.357). These findings require confirmation in larger human cohorts.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149127604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Guizi Liang, Jiangyu Han, Xiaolan Huang, Xing Chen, Dongwei Xie, Limei Liang, Rentao Zhi, Shengjiang Chen, Bulin Zhang, Yan Deng
{"title":"Deep Survival Modeling With Echocardiographic Myocardial Texture Radiomics for Prediction of Major Adverse Cardiovascular Events in Hypertrophic Cardiomyopathy.","authors":"Guizi Liang, Jiangyu Han, Xiaolan Huang, Xing Chen, Dongwei Xie, Limei Liang, Rentao Zhi, Shengjiang Chen, Bulin Zhang, Yan Deng","doi":"10.1007/s12265-026-10845-w","DOIUrl":"10.1007/s12265-026-10845-w","url":null,"abstract":"<p><p>Hypertrophic cardiomyopathy (HCM) carries substantial risk of major adverse cardiovascular events (MACE), yet current tools do not fully exploit quantitative myocardial texture from routine echocardiography. We retrospectively studied 413 patients with HCM from two tertiary centers to develop and externally validate a deep survival model integrating transthoracic echocardiographic texture radiomics with clinical and conventional echocardiographic variables. Patients from one center (n = 308) were used for development and internal testing and those from the other (n = 105) for external validation. The best-performing model was selected by cross-validated Harrell C-index and interpreted using Shapley additive explanations. During median follow-up of 30.7 and 35.6 months, 83 patients (20.1%) experienced a first MACE. The Combined model showed the highest concordance and net clinical benefit, with age, RadScore, left atrial diameter, and maximal wall thickness as leading contributors. This model may provide an accessible approach to individualised MACE risk stratification in HCM.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149110265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diagnostic Accuracy of Circulating MicroRNAs for Coronary Artery Disease: An Updated Systematic Review and Meta-analysis.","authors":"Shankar Biswas, Yashasvi Srivastava, Ayman Hamadttu","doi":"10.1007/s12265-026-10848-7","DOIUrl":"10.1007/s12265-026-10848-7","url":null,"abstract":"<p><p>Circulating microRNAs (miRNAs) are promising non-invasive biomarkers for coronary artery disease (CAD). We conducted an updated meta-analysis evaluating their diagnostic accuracy through December 2025. PubMed, Embase, and Scopus were searched for diagnostic accuracy studies of circulating miRNAs in angiography-confirmed CAD. Accuracy was pooled using a bivariate random-effects model yielding sensitivity, specificity, and SROC-AUC. Twenty-four studies (64 comparisons, 3,879 participants) were included. Pooled sensitivity was 0.777 (95% CI: 0.737-0.816), specificity 0.832 (95% CI: 0.801-0.862), and AUC 0.872. Multi-miRNA panels outperformed single miRNAs (AUC 0.901 vs. 0.868). Substantial heterogeneity was present (Sensitivity; I²=92.1%; τ²=0.738); however, τ² remained substantial (sens:0.738, tfpr:0.434), indicating persistent heterogeneity; Holling-adjusted I² (5.1-7.7%) reflects sensitivity to study precision, not resolved heterogeneity. Meta-regression identified panel-based assay type and plasma sample source as modifiable drivers. Circulating miRNAs show moderate-to-good diagnostic accuracy for CAD as investigational complementary biomarkers. Prospective validation with standardized protocols is required before clinical deployment. PROSPERO Registration ID: CRD420261279673. Not Applicable (As this is a Systematic Review and Meta-analysis and not a Clinical Trial).</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149110223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yan Yao, Fei Liu, Jie Meng, JinJing Zhang, MingXing Chen, Tianqing Cao
{"title":"Metabolite-based Analysis of High-Risk Factors on Occurrence of AKI in Patients with Acute Myocardial Infarction.","authors":"Yan Yao, Fei Liu, Jie Meng, JinJing Zhang, MingXing Chen, Tianqing Cao","doi":"10.1007/s12265-026-10849-6","DOIUrl":"10.1007/s12265-026-10849-6","url":null,"abstract":"<p><p>Current methods lack high‑risk identification for acute kidney injury (AKI) after acute myocardial infarction (AMI). This study aimed to develop a metabolic‑biomarker‑based predictive system. 124 AMI patients (July 2023-October 2024) were enrolled prospectively. Logistic regression, ROC curves, and Pearson correlation were used to assess predictive values. Post-PCI kidney injury incidence was 19.39% (n = 19). The injury group showed higher LVEF, FFA, and Killip ≥ 2 rates (P < 0.05), but lower 5-MTP and UMOD (P < 0.05). FFA, 5-MTP, and UMOD were independent risk factors (P < 0.05), with combined AUC = 0.931 (superior to single markers, P < 0.05). BUN, UA, SCr, and eGFR correlated strongly with these metabolites (P < 0.05). LVEF, 5‑MTP, and UMOD are key metabolic indicators for early AKI risk identification. The integrated \"biomarker+nursing\" pathway improves early warning and outcomes in AMI patients.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13623802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149080879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Suppression of Calpain Attenuates Coxsackievirus B3-Induced Myocarditis by Regulating RIPK1/RIPK3/MLKL Pathway.","authors":"Yuxi Liu, Yong Wang, Guijian Liu, Fei Yi, Dongyang Che, Zhiwei Chen, Yunzeng Zou, Ruizhen Chen","doi":"10.1007/s12265-026-10744-0","DOIUrl":"10.1007/s12265-026-10744-0","url":null,"abstract":"<p><p>Viral myocarditis caused by CVB3 inflicts substantial myocardial damage and predisposes to heart failure. Although necroptosis contributes to disease progression, the mechanisms governing this death pathway during CVB3 infection remain unclear. We found that calpain and its inhibitor Cast were dynamically expressed during CVB3 infection, correlating with cardiac damage, inflammation, and fibrosis. Further investigation revealed that CVB3 dynamically induced cardiomyocyte necroptosis by activating the RIPK1/RIPK3/MLKL pathway, which was prominently activated in the early acute phase but potentially attenuated in later stages. Immunofluorescence analysis supported the translocation of p-MLKL from the nucleus to the plasma membrane during disease progression. Importantly, both in vivo and in vitro experiments supported that calpain inhibition ALLN attenuated VMC via the RIPK1/RIPK3/MLKL pathway, and improved cardiac function post-CVB3 infection. The calpain activator PMMA exacerbated this process. Our findings reveal that calpain inhibition attenuated VMC by modulating the RIPK1/RIPK3/MLKL pathway, uncovering a novel regulatory mechanism in VMC.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13619709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149074791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}